Kinetics of photosensitivity in bath-PUVA photochemotherapy. 1998

C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
Department of Dermatology, Ruhr-University Bochum, Germany.

BACKGROUND Bath-PUVA is used to treat a variety of dermatoses. However, the kinetics of 8-methoxypsoralen during treatment are not completely clarified. OBJECTIVE The purpose of this study was to investigate the intensity of the phototoxic response and the persistence of phototoxicity after bath-PUVA. METHODS Twelve volunteers were exposed to UVA doses ranging from 0.5 to 40 J/cm2 from 10 to 240 minutes after bath-PUVA treatment. The resulting phototoxic response of the skin was determined. RESULTS Irradiation 10 minutes after the psoralen bath led to the lowest assessed minimal phototoxic dose (MPD) of 1.42 J/cm2 (mean, SD +/- 0.29). Thereafter, the MPD increased significantly and sharply every hour. At 4 hours after the psoralen bath, UVA doses up to 40 J/cm2 failed to induce any phototoxic erythema (MPD). CONCLUSIONS For optimal effects, UVA irradiation has to be administered immediately after the psoralen bath; no restrictive behavior is necessary after bath-PUVA treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001494 Baths The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc. Bath
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing
D017484 Dermatitis, Phototoxic A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin. Dermatitis, Contact, Phototoxic,Phototoxicity,Phototoxic Contact Dermatitis,Phototoxic Dermatitis,Contact Dermatitides, Phototoxic,Contact Dermatitis, Phototoxic,Dermatitides, Phototoxic,Dermatitides, Phototoxic Contact,Dermatitis, Phototoxic Contact,Phototoxic Contact Dermatitides,Phototoxic Dermatitides

Related Publications

C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
October 1995, Archives of dermatology,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
November 1997, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
May 1994, Lancet (London, England),
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
January 1998, Photodermatology, photoimmunology & photomedicine,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
October 2000, Photodermatology, photoimmunology & photomedicine,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
April 2001, Journal of the American Academy of Dermatology,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
November 1997, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
January 2008, European journal of dermatology : EJD,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
November 1996, Archives of dermatology,
C Gruss, and S Behrens, and T Reuther, and L Husebo, and N Neumann, and P Altmeyer, and P Lehmann, and M Kerscher
October 1992, The British journal of dermatology,
Copied contents to your clipboard!